Idhifa (Enasidenib)
- Medicine Name: Idhifa
- Generic Name: Enasidenib
- Dosage Form & Strength: Tablets: 50 mg or 100 mg
- Manufactured By: Celgene Corporation
Medical Uses
Idhifa is an isocitrate dehydrogenase-2 inhibitor used for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation.
Recommended Dosage: Select patients for the treatment of acute myeloid leukemia (AML) with Idhifa based on the presence of IDH2 mutations in the blood or bone marrow.
The recommended starting dose is 100 mg taken orally (by mouth) once daily with or without food until the disease is progressive or unacceptable toxicity occurs. For those without disease progression or unacceptable toxicity, treat for a minimum of six months to enable time for clinical response.
It is not advisable to split or crush the tablets. Administer tablets of Idhifa 100 mg by mouth persistently every day.
If a dose is vomited, missed, or not taken at the usual time, administer the dose as quickly as possible on the same day, and return to the normal schedule the following day.
Warning & Precautions
- Evaluate blood counts and blood chemistries for leukocytosis and tumor lysis syndrome (TLS) prior to the start of Enasidenib and monitor at a minimum of every 14 days for at least the first 3 months during treatment. Manage any kind of abnormalities promptly.
- Patients treated with Enasidenib may experience differentiation syndrome, which may be fatal or life-threatening if not treated. Differentiation syndrome is related to rapid proliferation and differentiation of myeloid cells.
- In case of differentiation syndrome, initiate oral or intravenous corticosteroids (e.g., 10 mg dexamethasone every 12 hours) and hemodynamic monitoring until improvement. Hospitalization for close observation and evaluation of patients with pulmonary or renal manifestation is required.
- Enasidenib 100 mg can cause embryo-fetal harm if used by a pregnant woman. Males with female partners of reproductive age should use effective contraception throughout treatment and for at least 30 days after the last dose. Pregnant females, patients becoming pregnant while on Enasidenib, or male patients with pregnant female partners must be apprised of the potential risk to the fetus.
- Women taking treatment with Enasidenib tablets should not breastfeed during treatment and for at least 30 days (1 month) after the final dose of Enasidenib.
Documentation & Availability
What documents are required to import IDHIFA to India?
IDHIFA (enasidenib) tablets can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of India).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is IDHIFA available in India?
IDHIFA (enasidenib tablets) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
S S Healthcare (S S Healthcare) helps import cancer medicines on the named patient supply (NPS). S S Healthcare is facilitator providing input
- On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
- Medicine Price.
- Finding Genuine and reliable source from Canada, Europe, USA and Australia
- Ensuring 100% transparency.
IDHIFA can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.
S S Healthcare (S S Healthcare) can facilitate the supply of IDHIFA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-7575883015 | Number: +91-7575883015 or write us at sshealthcare1012@gmail.com for Idhifa price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
S S Healthcare is able to source the IDHIFA (Cancer Treatment Medicines) from across the globe, and has the ability to supply. S S Healthcare offers its customers worldwide access to the best available treatment.
S S Healthcare is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
FAQ
What is the Generic Name for the trade name drug Idhifa®?
Enasidenib is Generic Name for the trade name drug Idhifa®.
What is the Manufacturer Name of Idhifa®?
Idhifa® is manufactured by Celgene Corporation.
Is Idhifa® approved by the FDA?
Yes, Idhifa® is approved by the FDA. Date of first/initial approval: August 1, 2017.
Where can I get Idhifa® at the best price in India?
To get the best IDHIFA- enasidenib price in India, contact S S Healthcare (a WHO-GDP and ISO 9001:2008 authorized Company). A valid medical prescription is required while buying Idhifa®.
What is the dosage and form of Idhifa® supplied?
Idhifa® is supplied as Tablets: 50 mg or 100 mg for oral administration.
What are the most common side effects with Idhifa®?
The most common side effects with Idhifa® include: elevated bilirubin, nausea, vomiting, diarrhea, and decreased appetite.
How much does Idhifa® cost in India?
Idhifa cost in India is less and can vary. In order to buy or procure this AML medication authentically, you can Call or WhatsApp: +91-7575883015 or send mail to sshealthcare1012@gmail.com.
What are the storage conditions of Idhifa®?
Store at 20-25°C (68-77°F); excursions permitted between 15-30°C (59-86°F). Keep the bottle well closed. Store in the original bottle (with a desiccant canister) in order to protect from the moisture.
Is it safe to buy Idhifa® online from India?
Yes, You can buy Idhifa online in India at the best price from the S S Healthcare if Idhifa® has not been approved or is not available in your country.
What are the Highlights of prescribing information for Idhifa®?
Click Here to download full Idhifa prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Email Address
Sshealthcare1012@gmail.com
+91 7575883015
Landline
079 48916267
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners, and S S Healthcare does not lay any claim on them. We only provide information.
